Ihc-Guide v12
Ihc-Guide v12
Immunohistochemistry
ptglab.com
TABLE OF CONTENTS
Introduction to Immunohistochemistry . . . . . . . . . . . . . . . . . . . 4
General Protocols . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Tissue Preparation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Tissue Preparation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Antigen Retrieval . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Blocking . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Immunostaining . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Signal Detection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Contact Us . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
ON THE COVER: Top left: IHC analysis of human liver tissue using CYC1
IHCeasy Kit (KHC0245). Bottom right: IHC analysis of human colon tissue
using Cytokeratin 19 antibody (10712-1-AP).
Introduction to
IMMUNOHISTOCHEMISTRY
Immunohistochemistry (IHC) enables the visualization of proteins in tissue while
retaining its microstructure. It helps to demonstrate the exact position and
distribution of the protein of interest in the analysed tissue section. You can then
visualize direct comparisons between experimental or pathological states, e.g.
between healthy and diseased tissues. During an IHC experiment, the protein of
interest (antigen) is detected by the binding of a primary antibody. This antibody-
antigen interaction is then visualized via chromogenic or fluorescent detection using
a secondary antibody.
For an IHC experiment to provide the best results, several steps of the IHC
protocol may require optimization to ensure specific antibody binding and optimal
visualization of the target protein. An IHC protocol can be influenced by various
factors, thus we must find the best working conditions to get strong and specific
staining.
The following guide outlines the general IHC protocol, as well as some useful tips
and hints on how to optimize each step.
Mounting Section
on Coated Slide
60% Alcohol 80% Alcohol 95% Alcohol 100% Alcohol Xylene
Deparaffinization & Rehydration
Secondary Antibody
Incubation
Fluorescent Chromogenic
Detection Detection
• Embedding
Move cassettes onto an embedding station.
Using a mold made of thick plastic or stainless steel, coat the bottom layer
of the mold with molten paraffin.
Place the tissues on top of the base wax orienting them as desired. Partially
cover with more paraffin. Place the cassette on top of the mold and completely
fill the mold.
Place mold with tissues on a cold plate to solidify. The paraffin will solidify
in 10-15 minutes.
Remove embedded tissues from the mold. Store at room temperature.
• Place the tissue block (freshly dissected, <5mm thick) onto a mold.
• Use cryo-embedding media (e.g. OCT) to fully cover the entire tissue block.
• Completely freeze the tissue on the base mold by submersion in liquid nitrogen.
• Store the frozen tissue block at -80°C until ready for sectioning. (See section on
frozen sectioning below.)
• Once sectioned, fix slides by incubating them in either ice-cold acetone (-20 ºC)
for 20 minutes or 4% paraformaldehyde (PFA).
• Embed the tissues in OCT medium using a mold and freeze by submersion in
liquid nitrogen.
• Store the tissues at -80°C until ready for sectioning.
IHCeasy Kits IHC Prep & Detect Kits IHC Detect Kits
Target-specific, complete IHC Kits for developing complete IHC Kits for highly-sensitive
workflow kits containing pre- workflows using any primary chromogenic signal
optimized primary antibody antibody of choice detection
Antigen
Retrieval Buffer
Washing Buffer
Blocking Buffer
Quenching buffer
Primary Antibody
Dilution Buffer
Primary Antibody
Secondary
Antibody
Chromogen
Signal Enhancer
Counter Staining
Reagent
Mounting Media
Control Slide
(optional)
Step-by-Step
Protocol
ptglab.com
TISSUE
SECTION
PREPARATION
HEADER
TISSUE PREPARATION
Correct processing of tissue samples prior to staining them with desired antibodies
plays a critical role in determining the success of an IHC experiment. Once tissues
are harvested it is important to fix or freeze them as soon as possible to prevent their
degradation. Tissues can be either fixed in formalin followed by their embedding
in paraffin (IHC-FFPE) or they can be frozen (IHC-Fr) followed by their fixation in
formaldehyde or alcohol before or after cryosectioning. While fixation helps preserve
tissue morphology and target antigenicity, embedding in a solid medium such as
paraffin provides support to the tissues during sectioning.
ANTIGEN RETRIEVAL
Aldehyde-based fixatives such as paraformaldehyde or formalin act by creating
cross-links between proteins in the tissue. In some cases, these cross-links mask
epitopes, inhibiting antigen access by antibodies and resulting in weak or absent
staining. Fortunately, this negative fixation effect can be reversed by a process called
antigen retrieval. The type and method of antigen retrieval that works best depends
on the tissue type and primary antibody. Our product-specific protocols state which
method is best for each of our antibodies, validated using IHC.
Protease K None
KRT20 mAb (60183-1-Ig), human colon tissue
HIER acts by using thermal energy to break down the cross-links that bind to the
surrounding proteins or peptides. Another mechanism by which HIER is thought to
act is through removing calcium ions from the site of protein cross-links, a theory
that is supported by the fact that some HIER buffers such as Tris-EDTA are calcium
chelators.
HIER PIER
Uses Most common, Good for difficult epitope recovery
gentle epitope retrieval Can damage tissues
pH and Buffer Tris-EDTA pH9 most used; pH 7.4; proteinase K, trypsin,
Citrate buffer pH6; or other pepsin, pronase
buffers at neutral pH
Temperature* 95ºC 37ºC
Incubation Time* ~20 minutes ~10–15 minutes
* Optimal conditions always have to be determined by each laboratory and in accordance with the specific product
information.
BLOCKING
Blocking is essential to prevent non-specific binding of the antibody or other
reagents to the tissue. Even though the antibody might be specific, it can also
show avidity for other epitopes. Antibody-antigen binding is affected by different
intermolecular forces (e.g. hydrophobic binding, ionic interactions) and these forces
can result in non-specific binding to endogenous molecules, serum proteins, or
others. Non-specific binding then prevents visualization of the antigen-antibody
binding of interest. Therefore, prior to incubation with the primary antibody, a
blocking step should be carried out to block the entire epitopes on the tissue
without damaging the desired epitope. Different commercial buffer systems are
available.
Serum/Protein Blocking
Serum (from the same species as the secondary antibody) or bovine serum albumin
(BSA) is commonly used for blocking. Sera and BSA can help to prevent non-specific
binding to the many hydrophobic side chains of proteins present in tissues. When
multiplexing, blocking serum of all the hosts of the secondary antibodies is required
(e.g. using normal goat and donkey serum). If BSA is used, the addition of 0.1-0.5%
Triton-X or Tween can act as an additional blocking reagent to prevent unspecific
binding.
No Effects of Quenching
Quenched
with
3% H2O2
Not
quenched
IMMUNOSTAINING
Selecting and optimizing antibodies for IHC
High-quality antibodies are desirable for their high specificity and low cross-reactivity,
generating reliable and successful staining. When choosing a primary antibody for
IHC, there are certain factors that you should consider:
• Number of citations in the desired application(s)
• Consult the literature and antibody comparison resources.
• View the in-house validation data from the antibody manufacturer to ensure that
the antibody is validated in the correct application in native samples.
OVER
9,000
Primary Antibodies
for IHC
IHC controls
To ensure that the observed staining pattern is specific and not due to any cross-
reactivity or non-specific binding, it is important to include control slides as part of
your experimental design. Controls must be run alongside the main experiment.
Reagent controls
Secondary only control • Reveals level of autofluorescence/
• Process the slide as normal but omit artefacts
the primary antibody. Isotype control
• Ensures signal detected is specific for • Replace the primary antibody with a
the target non-immune IgG of the same species,
• Test all fluorophores in isolation isotype and concentration as the
primary antibody.
Endogenous only control
• Ensures observed signal is specific of
• Process the slide as normal but omit FAB paratrope-epitope binding
the primary AND secondary antibody.
HC
IHC pen. rop
ho
b ic I
d
Hy
SIGNAL DETECTION
After incubation with a primary antibody, there are a few choices when it comes to
signal detection: chromogenic or fluorescent, and direct or indirect.
Chromogenic Detection
Chromogenic IHC antibodies commonly use conjugations with enzymes such
as horseradish peroxidase (HRP) or alkaline phosphatase. When these enzymes
encounter their substrate, they produce a dark precipitate, which can then be
visualized using a light microscope. DAB (3,3’-diaminobenzidine) is the substrate of
HRP and is the most used chromogen. DAB is insoluble, extremely stable, and heat
resistant, thus making it a good choice for many researchers.
For detecting low-abundance targets, additional steps are often necessary for
amplifying the primary antibody signal. While methods like avidin-biotin complex
(ABC) detection or labeled streptavidin-biotin (LSAB) detection exploit the high-
affinity complex between biotin and avidin for signal amplification, polymer-based
amplification is biotin-free and utilizes a polymer backbone with multiple enzyme
molecules.
Biotin
Avidin
Reporter Enzyme
Biolinylated
Secondary Antibody
Primary Antibody
Tissue Antigen
Biotin
Streptavidin
Reporter Enzyme
Biolinylated
Secondary Antibody
Primary Antibody
Tissue Antigen
Polymer-based Detection
• Preferred method of detection when endogenous biotin, present in some tissues,
leads to high background with the ABC or LSAB methods
• Utilizes secondary antibodies directly conjugated to a polymer backbone
containing multiple enzyme molecules
Advantages
• More sensitive compared to the ABC and LSAB methods
• Shorter protocol compared to the ABC and LSAB methods
Limitations
• May hinder tissue penetration due to the larger size of the polymer backbone
Reporter Enzyme
Dextran Backbone
Biolinylated
Secondary Antibody
Primary Antibody
Tissue Antigen
Fluorescence Detection
As an alternative to enzymatic detection, fluorescent signal detection during IHC can
be performed using fluorophore-conjugated antibodies. The basic premise behind
fluorescence detection is that the conjugated fluorophore is excited by a certain
wavelength of light, which then undergoes a change in conformation, resulting in a
lowering of energy state called the “Stokes shift.” Light is then is emitted at a longer
wavelength. Specialized fluorophores emit distinct excitation/emission spectra,
meaning that you can image multiple target proteins in the same sample using
different detection fluorophores, which is called multiplexing. Multiplexing can be
done by using primary antibodies that are raised in different hosts, and can thus be
targeted by different secondaries. Alternatively, this can be performed using directly
conjugated primary antibodies (see the section below).
Labeling Steps: a 1 b 2 c 3
Primary Antibody
1 2 3
a Rabbit-anti-antigen 1
b Mouse-anti-antigen 2
c Goat-anti-antigen 3
a b c
Secondary Antibody
1 Donkey-anti-rabbit A488
2 Donkey-anti-mouse A546
3 Chicken-anti-goat A594
Antigen 1 Antigen 2 Antigen 3
Fluorescence Chromogenic
Excellent Multiplexing Greater sensitivity
Indirect Direct
Fluorochrome
Fluorochrome
Secondary
Antibody
Primary
Antibody
Primary
Antibody Antigen Antigen
Indirect Staining
IF analysis of human kidney tissue using PTPRO antibody (67000-1-Ig, Clone: 2F2B4 ) and CoraLite594-Conjugated AffiniPure Goat
Anti-Mouse IgG(H+L), ACE2 antibody (21115-1-AP, green) and CoraLite488-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L).
Direct Staining
IF analysis of human lung cancer tissue using CoraLite®️ Plus 488 CD3 antibody (CL488-60181, Clone: 3F3A1 ), CoraLite®️555
pan-keratin antibody (CL555-26411, orange), and CoraLite®️ Plus 647 CD20 antibody (CL647-60271, Clone: 4A7G3, Magenta).
GO DIRECT WITH
CoraLite®
Fluorescent Dye-Conjugated Antibodies
Common
TROUBLESHOOTING TIPS
No/Weak Staining
POTENTIAL CAUSE SUGGESTED SOLUTION
Uneven staining
POTENTIAL CAUSE SUGGESTED SOLUTION
Proteintech Singapore
P +65 9785 0861
E [email protected]
ptglab.com